---
title: Clarenta vs YPrime
slug_a: comac-medical
slug_b: yprime
site: cro
review_signal_gate: closed
canonical_path: /compare/comac-medical/yprime
generated_by: BioBM Editorial AI
---

# Clarenta vs YPrime

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Clarenta (comac-medical) is listed for cro. Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.

Services: 8. Modalities: 0. Indications: 7. Locations: 10. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (10).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

YPrime (yprime) is listed for cro. YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.

Services: 10. Modalities: 0. Indications: 7. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.